$AGNPF Algernon Pharmaceuticals Inc. operates as a clinical stage drug development company. The Company focuses on the areas of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), and inflammatory bowel disease (IBD). Algernon Pharmaceuticals serves patients and customers in Canada.
https://www.bloomberg.com/quote/AGN:CN